Vilazodone for Corticosteroid-Induced Memory Impairment

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Memory Impairment
Interventions
DRUG

Vilazodone

Participants will be randomized to either vilazodone or placebo titrated as follows: 10 mg x 7 days, 20 mg x 7 days and 40 mg x 5 days.

DRUG

Placebo

DRUG

Hydrocortisone

Participants receive 160 mg x 4 days after vilazodone or placebo pre-treatment

Trial Locations (1)

75390

UT Southwestern Medical Center, Dallas

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER